Exhaled CO from NY1DD mice 24 hours prior to administration (baseline) and for 2 3-hour periods following intravenous MP4OX or MP4CO (12 mL/kg). Values are means + standard deviation (SD). N = 4 mice per treatment with the same mice used at each of the 3 time points. *P < .025 for MP4CO vs baseline.